Company / AR per Share
Ultragenyx Pharmaceutical Inc. AR per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$1.71
FY2025
5-year range
$0.43 / $1.71
FY2021-FY2025
Trend
+15.2%
vs FY2024
Sector context
#45 of 113
Health Care
What the data says
At $1.71, Ultragenyx Pharmaceutical Inc.'s ar per share ranks #45 of 113 in the Health Care sector. AR per Share has increased for 5 consecutive years, from $0.40 in FY2020 to $1.71 in FY2025.
Based on SEC 10-K filings.
1.71 in FY2025 with a 5-year CAGR of +33.7%.
Improved from $1.05 to $1.71 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +43.1%
- 5-Year CAGR
- +33.7%
- 10-Year CAGR
- -
Sector benchmark
#45 of 113 in Health CareTop 40% of 113This company $1.71 Sector average $28.83
▼
-94.1% below sector average
Key checks
Key Insights
- Ultragenyx Pharmaceutical Inc.'s ar per share has grown for 5 consecutive years.
- In FY2025, ar per share increased 15.2% year-over-year.
- Ranks #45 out of 113 companies in the Health Care sector.
- Lowest ar per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -2.91 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.71 | +15.2% |
| FY2024 | $1.48 | +41.8% |
| FY2023 | $1.05 | +79.3% |
| FY2022 | $0.58 | +37.1% |
| FY2021 | $0.43 | +6.6% |
| FY2020 | $0.40 | -38.2% |
| FY2019 | $0.65 | +123.9% |
| FY2018 | $0.29 | +130.0% |
| FY2017 | $0.13 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026